Michael J. Farrell Resmed Inc (RSMDF) insider trading activity

Michael J. Farrell is Chief Executive Officer of RESMED INC. Currently has a direct ownership of 455,472 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Oct 16, 2023, when has been sold 5,675 shares (ResMed Common Stock) at a price of $57.76 per share, resulting in proceeds of $327,788. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 455K

0% 3M change

3.84% 12M change

Total Value Held $0

Michael J. Farrell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 16 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.23%	455,035 ResMed Common Stock
Sep 15 2023	SELL Open market or private sale	$830,536 $146.35 p/Share	5,675 Reduced 1.25%	449,360 ResMed Common Stock
Sep 15 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.23%	455,035 ResMed Common Stock
Aug 17 2023	BUY Grant, award, or other acquisition	-	12,430 Added 2.69%	449,360 ResMed Common Stock
Aug 15 2023	SELL Open market or private sale	$1,039,659 $183.2 p/Share	5,675 Reduced 1.28%	436,930 ResMed Common Stock
Aug 15 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,605 ResMed Common Stock
Jul 17 2023	SELL Open market or private sale	$1,255,707 $221.27 p/Share	5,675 Reduced 1.28%	436,930 ResMed Common Stock
Jul 17 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,605 ResMed Common Stock
Jun 15 2023	SELL Open market or private sale	$1,233,688 $217.39 p/Share	5,675 Reduced 1.28%	436,930 ResMed Common Stock
Jun 15 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,605 ResMed Common Stock
May 15 2023	SELL Open market or private sale	$1,317,167 $232.1 p/Share	5,675 Reduced 1.28%	436,930 ResMed Common Stock
May 15 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,605 ResMed Common Stock
Apr 17 2023	SELL Open market or private sale	$1,272,505 $224.23 p/Share	5,675 Reduced 1.28%	436,900 ResMed Common Stock
Apr 17 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,575 ResMed Common Stock
Mar 15 2023	SELL Open market or private sale	$1,174,441 $206.95 p/Share	5,675 Reduced 1.28%	436,900 ResMed Common Stock
Mar 15 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,575 ResMed Common Stock
Feb 15 2023	SELL Open market or private sale	$1,219,160 $214.83 p/Share	5,675 Reduced 1.28%	436,900 ResMed Common Stock
Feb 15 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,575 ResMed Common Stock
Jan 17 2023	SELL Open market or private sale	$1,273,243 $224.36 p/Share	5,675 Reduced 1.28%	436,900 ResMed Common Stock
Jan 17 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,575 ResMed Common Stock
Dec 15 2022	SELL Open market or private sale	$1,223,700 $215.63 p/Share	5,675 Reduced 1.28%	436,900 ResMed Common Stock
Dec 15 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,575 ResMed Common Stock
Nov 23 2022	SELL Payment of exercise price or tax liability	$7,458,831 $224.4 p/Share	33,239 Reduced 7.07%	436,900 ResMed Common Stock
Nov 23 2022	BUY Grant, award, or other acquisition	-	56,115 Added 10.66%	470,139 ResMed Common Stock
Nov 15 2022	SELL Open market or private sale	$1,274,832 $224.64 p/Share	5,675 Reduced 1.35%	414,024 ResMed Common Stock

Also insider at

ZBH

ZIMMER BIOMET HOLDINGS, INC. Healthcare

Director

MJF